The Journal of
Clinical Psychiatry

Psychiatry

Article July 15, 2009

Results of Expert Consensus Survey on Adherence 2008

J Clin Psychiatry 2009;70(suppl 4):1-37

Article Abstract

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 85 • 2024 • Number 4

Read the Current Issue

Meta-Analysis

Changes in Cognition in Patients With Schizophrenia

Systematic Review

Diagnostic Assessment via Telehealth vs Face-to-Face

Original Research

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Original Research

Bridge Symptoms Between Borderline Personality and PTSD

Original Research

Gepirone-ER and Sexual Function in Patients with MDD

Original Research

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

View current Issue

Related Articles

Article

Hypercalcemia and Psychosis

November 29, 2018

Have you ever considered hypercalcemia as a possible cause of your patient's psychiatric symptoms? The objective of this article is to help clinicians make an accurate diagnosis by considering...

Ermal Bojdani, Tina Zhang, Syona Shetty, et al

Article

Trichotillomania Therapy

November 22, 2018

Trichotillomania is characterized by recurrent episodes of hair pulling and affects a growing and diverse population. This review provides an analysis of current treatment modalities and highlights the need...

Mohammad Jafferany, Arsh Patel

Article

Lithium Monitoring in Older Adults

November 20, 2018

Lithium treatment, while effective for mood disorders, necessitates frequent drug level and renal monitoring in older patients to prevent serious adverse events. Read this article to see if older...

Soham Rej, Nathan Herrmann, Andrea Gruneir, et al